MetaCap

Atara Biotherapeutics Statistics

NASDAQ: ATRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

6.33-0.01 (-0.16%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Atara Biotherapeutics by the numbers

Atara Biotherapeutics has a market capitalization of $64.5 million based on 10.19M shares outstanding. With trailing EPS of $-1.12, Atara Biotherapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 26.4% below its 50-day average and 19.6% below its 200-day average.

Average daily trading volume is 35.46K shares, or about $224,487 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ATRA valuation vs. peer median

ATRA compared with the median of 8 peer companies
MetricATRAPeer medianDifference
Market cap$64.49M$58.78M+10%
Avg. volume35.46K1.08M-97%

Peer median across 8 companies: TNYA, NMRA, CRDF, CSBR, CHRS, OKYO, CGTX, AVXL.

Valuation

Market cap
$64.49M
Price / sales (latest FY)
0.53
EPS (TTM)
$-1.12

Price and trading

Previous close
6.34
Open
6.25
Day range
6.25 – 6.85
52-week range
3.92 – 19.15
52-week change
-53.73%
Beta
—
Volume
36.42K

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
64.49M
Forward Pe
3.96
Eps
-1.12
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
19.15
Week52 Low
3.92
Avg Volume
35,464.00
Shares Outstanding
10.19M
Ma50
8.61
Ma200
7.87
Earnings Date
Nov 10, 2026
Pct From52w High
-66.94%
Pct From52w Low
61.48%

Related